Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
09/2014
09/18/2014US20140271676 Fc containing polypeptides with altered glycosylation and reduced effector function
09/18/2014US20140271675 Therapeutic uses for vegfr1 antibodies
09/18/2014US20140271672 Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof
09/18/2014US20140271668 Increasing parkin activity by administering a deubiquitinating enzyme inhibitor
09/18/2014US20140271667 Methods and Compositions for Neoadjuvant Therapy
09/18/2014US20140271666 Use of anti-eotaxin antibodies for treating inflammatory bowel disease
09/18/2014US20140271664 Therapeutic use of antibodies to hgf
09/18/2014US20140271663 Use of anti-eotaxin antibodies for treating inflammatory bowel disease
09/18/2014US20140271661 Monoclonal antibodies against antithrombin beta
09/18/2014US20140271660 Monoclonal antibodies against antithrombin beta
09/18/2014US20140271659 Anti-prolactin receptor antibody formulations
09/18/2014US20140271658 Anti-il-33 antibodies and uses thereof
09/18/2014US20140271656 Optimized antigens of pneumocystis and use thereof
09/18/2014US20140271655 Neutralizing anti-influenza a virus antibodies and uses thereof
09/18/2014US20140271654 Methods for treating bone gap defects
09/18/2014US20140271653 Human antibodies to respiratory syncytial virus f protein and methods of use thereof
09/18/2014US20140271652 Immunologically active polypeptide
09/18/2014US20140271651 Anti-GP73 monoclonal antibodies and methods of obtaining the same
09/18/2014US20140271648 Interferon Alpha and Omega Antibody Antagonists
09/18/2014US20140271647 Pan-ELR+ CXC CHEMOKINE ANTIBODIES
09/18/2014US20140271646 Monospecific and bispecific human monoclonal antibodies targeting insulin-like growth factor ii (igf-ii)
09/18/2014US20140271645 Method for treating inflammation
09/18/2014US20140271643 Human notch1 decoys
09/18/2014US20140271641 Thrombospondin-1 polypeptides and methods of using same
09/18/2014US20140271639 Semaphorin 7a Induced Lung Fibrogenesis Occurs in a CD-4-Dependent, Macrophage Dependent Manner
09/18/2014US20140271637 Methods of administering anti-tnfalpha antibodies
09/18/2014US20140271636 Formulation of an antibody and use thereof
09/18/2014US20140271635 Treatment of cancer using humanized anti-cd19 chimeric antigen receptor
09/18/2014US20140271633 Mammalian cell culture performance through surfactant supplementation of feed media
09/18/2014US20140271632 Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosaccharides
09/18/2014US20140271629 Chrdl-1 antigen binding proteins and methods of treatment
09/18/2014US20140271628 Humanized, anti-n2 antibodies
09/18/2014US20140271627 Humanized, anti-n2 antibodies
09/18/2014US20140271626 MUTATED ANTI-TNFa ANTIBODIES AND METHODS OF THEIR USE
09/18/2014US20140271625 Methods for treating bleeding disorders
09/18/2014US20140271624 Anti-notch nrr antibodies and methods using same
09/18/2014US20140271623 Modulation of complement-dependent cytotoxicity through modifications of the c-terminus of antibody heavy chains
09/18/2014US20140271622 Methods of cell culture
09/18/2014US20140271618 Antibodies to carcinoembryonic antigen-related cell adhesion molecule (ceacam)
09/18/2014US20140271614 Directed sequence polymer compositions and antibodies thereof for the treatment of protein conformational disorders
09/18/2014US20140271582 Cd123-specific chimeric antigen receptor redirected t cells and methods of their use
09/18/2014US20140271478 Antibodies that bind integrin alpha-v beta-8
09/18/2014US20140271464 Therapeutic use of antibodies to hgf
09/18/2014US20140271463 Bri2 as a novel biomarker for alzheimer's disease
09/18/2014US20140271462 Antigen binding constructs to cd8
09/18/2014US20140271459 Antibodies to hgf and compositions containing
09/18/2014US20140271458 DUAL SPECIFIC BINDING PROTEINS DIRECTED AGAINST IL-1 and/or IL-17
09/18/2014US20140271457 Dual Specific Binding Proteins Directed Against TNF
09/17/2014EP2778176A1 Compositions and methods for analyzing histidine phosphorylation
09/17/2014EP2778175A1 Humanized anti-interleukin 3 receptor alpha chain antibodies for use in treating acute myeloid leukemia (AML)
09/17/2014EP2778174A1 Antibody specific to profilaggrin c-terminal domain, and use thereof
09/17/2014EP2778173A1 Antibody directed against anthrax toxins and its uses
09/17/2014EP2777714A1 Method of producing an immunoligand/payload conjugate by means of a sequence-specific transpeptidase enzyme
09/17/2014EP2776565A1 Methods and compositions for treating diseases, disorders or injury of the nervous system
09/17/2014EP2776470A2 Antibodies specific for trop-2 and their uses
09/17/2014EP2776469A2 Antibody molecules having specificity for human ox40
09/17/2014EP2776468A2 Methods of inhibiting tumor growth by antagonizing il-6 receptor
09/17/2014EP2776467A1 Methods of treating inflammatory disorders using anti-m-csf antibodies
09/17/2014EP2776466A1 Albumin binding antibodies and binding fragments thereof
09/17/2014EP2776465A1 Monoclonal antibodies against serotransferrin antigens, and uses therefor
09/17/2014EP2776464A1 Antibody specific for trans - resveratrol and use thereof
09/17/2014EP2776463A1 Neutralizing gp41 antibodies and their use
09/17/2014EP2776462A1 Indolealkylamino-withasteroid conjugates and method of use
09/17/2014EP2776065A1 Combination therapies using anti- pseudomonas psl and pcrv binding molecules
09/17/2014EP2776032A2 Treatment of hematologic malignancies with an anti-cxcr4 antibody
09/16/2014US8835712 Transgenic trasnchromosomal rodents for making human antibodies
09/16/2014US8835619 Heat shock proteins from Mycobacterium leprae and uses thereof
09/16/2014US8835618 Mutations of the parkin gene
09/16/2014US8835611 Calicheamicin derivative-carrier conjugates
09/16/2014US8835610 IL-17 binding proteins
09/16/2014US8835609 Antigen binding sites to non-functional oligomeric P2X7 receptors and methods of use thereof
09/16/2014US8835608 Anti-MRP3 antibodies and methods of use
09/16/2014US8835607 Humanized antibodies
09/16/2014US8835606 Anti-cancer antibodies with reduced complement fixation
09/16/2014US8835603 Agents for the treatment of celiac disease
09/16/2014US8835361 High-throughput quantitation of crop seed proteins
09/16/2014US8835172 Modular functional peptides for delivery of nanoparticles
09/16/2014US8835167 Humanized anti-tag 72 CC49 for diagnosis and therapy of human tumors
09/16/2014US8835133 Humanized anti-beta7 antagonists and uses therefor
09/16/2014US8835119 Lectin pathway deficiency assay
09/16/2014US8835107 Coronavirus, nucleic acid, protein, and methods for the generation of vaccine, medicaments and diagnostics
09/16/2014US8834890 Siderophore conjugate immunogenic compositions and vaccines
09/16/2014US8834887 Drug for suppressing pathogen occurring in vivo
09/16/2014US8834886 Camptothecin-binding moiety conjugates
09/16/2014US8834883 Anti-VEGF antibodies and uses thereof
09/16/2014US8834882 Antibodies to CD70
09/16/2014US8834881 Human binding molecules capable of binding to and neutralizing influenza B viruses and uses thereof
09/16/2014US8834880 Antibodies directed to angiopoietin-2 and uses thereof
09/16/2014US8834879 Methods of treating fibroproliferative disorders of the kidney or reducing kidney fibrosis
09/16/2014US8834877 Anti-folate receptor alpha antibodies and uses thereof
09/16/2014US8834876 Therapeutic agent for hematopoietic tumors
09/16/2014US8834875 Notch1 binding agents and methods of use thereof
09/16/2014US8834874 Methods and compositions for increasing iduronate 2-sulfatase activity in the CNS
09/16/2014US8834873 Method for detecting and controlling cancer
09/16/2014US8834872 Uses of antibodies
09/16/2014US8834871 Immunoglobulin molecules with improved characteristics
09/16/2014CA2689726C Antibodies against gpi.alpha.
09/16/2014CA2631556C Functional epitopes of streptococcus pneumoniae psaa antigen and uses thereof
09/16/2014CA2624081C Method of identifying membrane ig specific antibodies and use thereof for targeting immunoglobulin-producing precursor cells
09/16/2014CA2574289C Human monoclonal antibodies against human il-4
1 ... 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 ... 1494